Literature DB >> 9656394

Pharmacokinetics and ex vivo anti-malarial activity of sera following a single oral dose of dihydroartemisinin in healthy Thai males.

K Na-Bangchang1, K Congpoung, R Ubalee, A Thanavibul, P Tan-anya, J Karbwang.   

Abstract

The pharmacokinetics of dihydroartemisinin (DHA) was studied in eight healthy male Thai subjects after a single oral dose of 300 mg. Absorption of oral DHA was rapid, Cmax of 679 (307-1000) ng/ml was observed at 1.5 (1-2.5) hours after dosing [median (range)]. Plasma concentrations declined monoexponentially and at 12 hours after administration, the levels were below the detection limit (3 ng/ml). A large variation in the AUC (approximately) 50% was observed. The median (range) AUC was 2010 (636-4079) ng h/ml. The lag time and absorption half-life (t1/2a) were 0.169 (0.111-0.277) hours and 0.709 (0.367-1.118) hours respectively. t1/2z was 1.25 (0.79-1.89) hours Vz/f and CL/f were 5.9 (3.5-8.2) l/kg and 45.3 (28.6-122.8) ml/min/kg, respectively. The pattern of its ex vivo serum activity coincided with the plasma concentrations of DHA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9656394

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria.

Authors:  T Q Binh; K F Ilett; K T Batty; T M Davis; N C Hung; S M Powell; L T Thu; H V Thien; H L Phuöng; V D Phuong
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

2.  First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.

Authors:  Johannes Nagelschmitz; Barbara Voith; Georg Wensing; Axel Roemer; Burkhard Fugmann; Richard K Haynes; Barbara M Kotecka; Karl H Rieckmann; Michael D Edstein
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.